Neurofilament light tracks SCA3 progression – Ataxia

Neurofilament light tracks SCA3 progression

Neurofilament light tracks SCA3 progression

Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease, is caused by a genetic mutation in the ATXN3 gene. SCA3 is thought to be the most common SCA worldwide, and currently there is no effective treatment for the condition.

Biomarkers are characteristics that can be measured, evaluated and used to indicate disease progression or the effect of a therapy. Biomarkers can also potentially be used to diagnose a condition before any symptoms occur.  It is important to find effective biomarkers for SCA3 to enable an early detection of the condition and to measure how well drugs are working in clinical trials.

Two recently published papers have suggested that a protein called neurofilament light could be a promising biomarker for SCA3. Neurofilaments are found in brain cells and are important in giving the cells structural support.

In a European project (find more details here), the levels of neurofilament light were measured in the blood of people with SCA3 and in a SCA3 animal model. The researchers found that the levels of neurofilament light were increased in people with SCA3 and this was associated with the severity and progression of the condition. Interestingly, levels of neurofilament light were increased 7.5 years before the expected onset of SCA3 symptoms. This increase in neurofilament light was also found in the SCA3 animal model and occurred before the loss of cells.

A study led by a group in China also found increased levels of neurofilament light in the blood of people with SCA3, which were linked to SCA3 severity. In addition, increased levels of neurofilament light were correlated with changes in the brain, such as a decreased gray matter volume in certain areas.

Overall, these findings suggest that neurofilament light is a promising biomarker for SCA3 and could be used to track SCA3 progression and the effect of therapies in future clinical trials.

Read the full articles here and here.

SUBSCRIBE TO OUR NEWSLETTER

Something went wrong. Please check your entries and try again.
fundraise image

FUNDRAISE FOR US

Take part in a challenge or create your fundraiser. Every penny you raise will help those affected by ataxia.

Donate Image

DONATE

To make either a one off or recurring donation which will help fund research into treatments and cures and supports those affected ataxia

Volunteer Image

VOLUNTEER WITH US

Support the ataxia community and volunteer with Ataxia UK. From social media to telephone befriending, there are loads of ways you can make a difference to someone's life.

Donate Now
Welcome to our new site! We hope you like it.
As it's brand new, there may be a few temporary glitches such as broken links - we are working on getting these all fixed ASAP. If you'd like to give us any feedback or let us know if something isn't quite right, please email website@ataxia.org.uk
+
Scroll to Top